Corona vaccine

Antibodies attack the corona virus. Illustration: depositphotos.com

Not all antibodies are created equal

Critically ill, recovering or vaccinated - how do the antibodies to corona that each of the groups produces differ and what are the unique characteristics of the antibodies acquired following vaccination
Corona vaccine in Israel. Illustration: depositphotos.com

The booster dose of the corona vaccine reduces the risk of getting sick 10 times compared to those vaccinated twice

This is according to a study by researchers from the Ministry of Health and universities and hospitals in Israel that examined data from over one million Israelis aged sixty and over who were vaccinated with two vaccines at most in March 2021. The comparison was between
Virus prevention system. Figure: Turtech nano fibers

Corona vaccine through the skin

Left: the structure of the ACE2 protein (the black outlines mark the binding site on the receptor). Right: The original binding site of the virus (top) compared to the "super-plug" (bottom). Decoding the protein structure was carried out by Dr. Nadav Elad from the Department of Chemical Research Infrastructures and Dr. Orli Diem from the Department of Life Science Research Infrastructures using a cryogenic electron microscope. Courtesy of the Weizmann Institute

put a stop to the epidemic

Through "evolution in a test tube" scientists of the Weizmann Institute of Science created a molecule that may be used as an effective cure for Corona
Results of a generally insured study on the effectiveness of the corona vaccine

A thorough study of 1.2 million general insureds proves: the corona vaccine is effective

Final results of the Klalit Research Institute regarding the effectiveness of corona vaccines are published in the medical journal The New England Journal of Medicine: after the first vaccine dose: 57% effectiveness in preventing morbidity and reducing
Corona vaccine. Photo: depositphotos.com

Can the corona virus develop resistance to vaccines?

A week ago a study was published in Nature in which the researchers described how they closely followed the evolution of the virus in the body of a cancer patient whose immune system was eliminated and discovered mutations that are able to deal with a large number
Pfizer's vaccine. Photo: depositphotos.com

About the Helsinki Committee - and the dance about the two weddings

In recent days there has been a big uproar regarding the Helsinki Committee, what it determined or did not determine, and what it means for the vaccine. So let's break down the issue, to understand what the Ministry of Health really did wrong, and what
Dr. Albert Burla, CEO of Pfizer. Photo: shutterstock

The Technion will award an honorary doctorate to Pfizer CEO Albert Borla

Dr. Borla will receive the title for his extraordinary achievement in leading the development of the innovative vaccine against SARS-CoV-2, the virus that causes the corona epidemic. The vaccine that helps to recover from the corona crisis is expected to be a model for the development of a variety
Corona vaccine. Illustration: depositphotos.com

Moderna reports receiving FDA approval for the company's COVID-19 vaccine

Moderna reported on Friday the receipt of FDA approval for the company's COVID-19 vaccine in the US, which will also be followed by approval for the vaccine in Israel as happened with Pfizer's vaccine last week
The process of developing the corona vaccine. Public relations photography, Moderna

Moderna applies to the FDA for emergency approval for the vaccine

Moderna announces the analysis of preliminary efficacy findings in the results of the phase 3 trial of its COVE vaccine for the treatment of COVID-19 as well as the submission of the trial findings for emergency approval by the FDA
mRNA vaccine for corona. Illustration: depositphotos.com

Moderna's COVID-19 vaccine achieved 94.5% efficacy in the clinical trial

A first interim analysis of the trial's findings included 95 participants who were infected with Corona, 90 of whom are from the control group * All five who got sick despite the vaccine were asymptomatic or in a mild condition * Israel between
Vaccines for babies. Illustration: depositphotos.com

"The higher the response rate to routine vaccinations, the lower the mortality rate from corona"

A new study conducted at the Safed Academic College reveals that the more children are vaccinated in the general population in a certain country, then the death rates among those infected with the corona in that country are lower

Pfizer and Biontech announce success in a clinical trial of a corona vaccine - 90 percent effective

This follows an interim analysis of a clinical trial that is in progress, in which it was found that out of 94 confirmed corona cases among the experimenters, only nine received the vaccine and the rest are from the control group that received a placebo
A vial of Jensen's COVID-19 vaccine currently in extensive clinical research in the US. Credit: Johnson & Johnson's Jensen Pharmaceuticals

A fourth clinical trial of a corona vaccine begins in the United States

This is a vaccine based on Jensen's Ebola vaccine. "Four vaccines in clinical trials is an unprecedented achievement by the scientific community made possible by decades of advances in vaccine technology and a strategic approach
Development of vaccines for corona. Illustration: jumpstory

When will there be a vaccine for the corona virus? Four scenarios

Development of drugs for corona. From jumpstory.com

Do not expect a corona vaccine this year